Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Amphastar Pharmaceuticals (AMPH) Short-Term Debt issuances (2018 - 2025)

Amphastar Pharmaceuticals has reported Short-Term Debt issuances over the past 7 years, most recently at $273000.0 for Q4 2025.

For Q4 2025, Short-Term Debt issuances fell 94.39% year-over-year to $273000.0; the TTM value through Dec 2025 reached $6.2 million, down 66.28%, while the annual FY2025 figure was $6.2 million, 66.28% down from the prior year.
Short-Term Debt issuances for Q4 2025 was $273000.0 at Amphastar Pharmaceuticals, up from $172000.0 in the prior quarter.
Over five years, Short-Term Debt issuances peaked at $500.0 million in Q2 2023 and troughed at -$25000.0 in Q2 2024.
A 3-year average of $58.3 million and a median of $4.1 million in 2024 define the central range for Short-Term Debt issuances.
Biggest five-year swings in Short-Term Debt issuances: tumbled 100.0% in 2024 and later skyrocketed 16616.0% in 2025.
Year by year, Short-Term Debt issuances stood at $500.0 million in 2023, then tumbled by 99.03% to $4.9 million in 2024, then plummeted by 94.39% to $273000.0 in 2025.
Business Quant data shows Short-Term Debt issuances for AMPH at $273000.0 in Q4 2025, $172000.0 in Q3 2025, and $4.1 million in Q2 2025.